A Double-blind Controlled Trial of the Effect of Sodium Cromoglycate in Preventing Relapse in Ulcerative Colitis

Overview

Journal Postgrad Med J

Publisher Oxford University Press

Specialty General Medicine

Date 1981 Jul 1

PMID 6118859

Citations 5

Authors

P J Whorwell

G M Whorwell

J BAMFORTH

D Colin Jones

P Down

A Edwards

A E GENT

P GOLDING

K R GOUGH

M D Hellier

P Isaacson

C A Loehry

C L Smith

R P Waldram

R Wright

Affiliations

Soon will be listed here.

Abstract

A double-blind controlled trial of the effect of sodium cromoglycate (SCG) in preventing relapse in ulcerative colitis has been completed in 100 subjects. In patients already taking sulphasalazine, SCG did not prove to be of any additional benefit. However, in patients not on any other maintenance therapy, the relapse rate was 40% for SCG as compared with 75% for placebo. A large study of the effect of SCG in patients intolerant of sulphasalazine is indicated.

Citing Articles

Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.

Kotlyar D, Shum M, Hsieh J, Blonski W, Greenwald D World J Gastroenterol. 2014; 20(32):11023-32.

PMID: 25170192 PMC: 4145746. DOI: 10.3748/wjg.v20.i32.11023.

Meta-analysis of the placebo response in ulcerative colitis.

Garud S, Brown A, Cheifetz A, Levitan E, Kelly C Dig Dis Sci. 2007; 53(4):875-91.

PMID: 17934839 DOI: 10.1007/s10620-007-9954-6.

Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.

Raithel M, Winterkamp S, Weidenhiller M, Muller S, Hahn E Int J Colorectal Dis. 2006; 22(7):833-9.

PMID: 16944185 DOI: 10.1007/s00384-006-0120-y.

Sodium cromoglycate in proctitis and ulcerative colitis.

Allan R Br Med J (Clin Res Ed). 1982; 284(6309):70-1.

PMID: 6119135 PMC: 1495651. DOI: 10.1136/bmj.284.6309.70.

Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis.

King T, Biddle W, Bhatia P, Moore J, Miner Jr P Dig Dis Sci. 1992; 37(4):490-5.

PMID: 1551335 DOI: 10.1007/BF01307568.

References

Dissanayake A, TRUELOVE S . A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut. 1973; 14(12):923-6. PMC: 1412871. DOI: 10.1136/gut.14.12.923. View

Heatley R, Calcraft B, Rhodes J, Owen E, Evans B . Disodium cromoglycate in the treatment of chronic proctitis. Gut. 1975; 16(7):559-63. PMC: 1410984. DOI: 10.1136/gut.16.7.559. View

Mani V, Lloyd G, Green F, Fox H, Turnberg L . Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial. Lancet. 1976; 1(7957):439-41. DOI: 10.1016/s0140-6736(76)91471-9. View

Azad Khan A, Howes D, Piris J, TRUELOVE S . Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut. 1980; 21(3):232-40. PMC: 1420362. DOI: 10.1136/gut.21.3.232. View

Dronfield M, Langman M . Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis. Gut. 1978; 19(12):1136-9. PMC: 1412316. DOI: 10.1136/gut.19.12.1136. View